Presently available biosimilars in hematology-oncology ― Part II: G-CSF : Les BiosimilairesGASCON, P.Oncologie (Paris). 2011, Vol 13, Num 5, pp 213-217, issn 1292-3818, 5 p.Article

Appayo de la percepción remóta a la prospección diamartifera = Appui de la télédétection à la prospection diamantifèreGASCON, P.1986, Num 15, pp 5-15, issn 0016-7975Article

Le Répertoire de vedettes-matière de la Bibliothèque de l'Université Laval: sa genèse et son évolution. II = The répertoire de vedettes-matière de l'Université de Laval: ilts begennings and its evolutionGASCON, P.Documentation et bibliothèques. 1994, Vol 40, Num 1, pp 25-32, issn 0315-2340Article

Le Répertoire de vedettes-matière de la Bibliothèque de l'Université Laval: sa genèse et son évolution (1ère partie) = The Répertoire de vedettes-matière de l'Université de Laval: its beginnings and its evolutionGASCON, P.Documentation et bibliothèques. 1993, Vol 39, Num 3, pp 129-139, issn 0315-2340Article

ELECTRICALLY INDUCED OPIATE-LIKE INHIBITION OF THE GUINEA-PIG ILEUM: CROSS-TOLERANCE TO MORPHINEPUIG MM; GASCON P; MUSACCHIO JM et al.1978; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1978; VOL. 206; NO 2; PP. 289-302; BIBL. 40 REF.Article

ENDORPHIN RELEASE: CROSS TOLERANCE TO MORPHIN.PUIG MM; GASCON P; MUSACCHIO JM et al.1977; EUROP. J. PHARMACOL.; NETHERL.; DA. 1977; VOL. 45; NO 2; PP. 205-206; BIBL. 5 REF.Article

Treatment of Kaposi's sarcomaGASCON, P; SCHWARTZ, R. A.Dermatologic clinics. 1994, Vol 12, Num 2, pp 451-456, issn 0733-8635Article

Induction of negative hematopoietic regulators by neurokinin-A in bone marrow stromaRAMESHWAR, P; GASCON, P.Blood. 1996, Vol 88, Num 1, pp 98-106, issn 0006-4971Article

TYPE III HYPERLIPOPROTEINEMIA ASSOCIATED WITH APOLIPOPROTEIN E DEFICIENCYGHISELLI G; SCHAEFER EJ; GASCON P et al.1981; SCIENCE; ISSN 0036-8075; USA; DA. 1981; VOL. 214; NO 4526; PP. 1239-1241; BIBL. 20 REF.Article

GANGRENA GASEOSA: A PROPOSITO DE 25 CASOS. = GANGRENE GAZEUSE. A PROPOS DE 25 CASMAS MARFANY J; RAMON SOLER R; BAXARIAS GASCON P et al.1977; MED. CIV.; ESP.; DA. 1977; VOL. 68; NO 4; PP. 157-160; ABS. ANGL.; BIBL. 15 REF.Article

Bone marrow failure: immunologic implications and treatment modalitiesBIELORY, L; GASCON, P.Annals of allergy. 1986, Vol 56, Num 2, pp 114-125, issn 0003-4738Article

Evaluación de lateritas ferro-aluminosas de la Gran Sabana en Venezuela = Evaluation des latérites ferro-alumineuses de la Gran Sabana du VénézuélaVASQUEZ, J. C; GASCON, P.1984, Num 12, pp 5-28, issn 0016-7975Article

Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma : potential autoregulatory role for these cytokines in SP receptor expression and inductionRAMESHWAR, P; GASCON, P.Blood. 1995, Vol 86, Num 2, pp 482-490, issn 0006-4971Article

Release of interleukin-1 and interleukin-6 from human monocytes by antithymocyte globulin : requirement for De Novo synthesisRAMESHWAR, P; GASCON, P.Blood. 1992, Vol 80, Num 10, pp 2531-2538, issn 0006-4971Article

SPONTANEOUS SUBARACHNOID HEMORRHAGE SIMULATING ACUTE TRANSMURAL MYOCARDIAL INFARCTIONGASCON P; LEY TJ; TOLTZIS RJ et al.1983; AMERICAN HEART JOURNAL; ISSN 0002-8703; USA; DA. 1983; VOL. 105; NO 3; PP. 511-513; BIBL. 8 REF.Article

Hematopoietic modulation by the tachykininsRAMESHWAR, P; GASCON, P.Acta haematologica. 1997, Vol 98, Num 2, pp 59-64, issn 0001-5792Article

Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemiaGROSSMAN, A; SILVER, R. T; ARLIN, Z et al.American journal of human genetics. 1989, Vol 45, Num 5, pp 729-738, issn 0002-9297Article

Circulating activated suppressor T lymphocytes in aplastic anemiaZOUMBOS, N. C; GASCON, P; DJEU, J. Y et al.The New England journal of medicine. 1985, Vol 312, Num 5, pp 257-265, issn 0028-4793Article

The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)AAPRO, M; MOLASSIOTIS, A; ROILA, F et al.Annals of oncology. 2012, Vol 23, Num 8, pp 1986-1992, issn 0923-7534, 7 p.Article

Serum HER2 extracellular domain predicts an aggressive clinical outcome and biological PSA response in hormone-independent prostate cancer patients treated with docetaxelDOMINGO-DOMENECH, J; FERNANDEZ, P. L; FILELLA, X et al.Annals of oncology. 2008, Vol 19, Num 2, pp 269-275, issn 0923-7534, 7 p.Article

Serum protein S-100 predicts clinical outcome in patients with melanoma treated with adjuvant interferon - comparison with tyrosinase RT-PCRDOMINGO-DOMENECH, J; MOLINA, R; GRAU, J. J et al.Oncology. 2005, Vol 68, Num 4-6, pp 341-349, issn 0030-2414, 9 p.Article

Effects of CERA (continuous erythropoietin receptor activator) in patients with advanced non-small-cell lung cancer (NSCLC) receiving chemotherapy: results of a phase II studyGASCON, P; PIRKER, R; DEL MASTRO, L et al.Annals of oncology. 2010, Vol 21, Num 10, pp 2029-2039, issn 0923-7534, 11 p.Article

Integrating concurrent navelbine and cisplatin to hyperfractionated radiotherapy in locally advanced non-small cell lung cancer patients treated with induction and consolidation chemotherapy: feasibility and activity resultsREGUART, N; VINOLAS, N; CASAS, F et al.Lung cancer. 2004, Vol 45, Num 1, pp 67-75, issn 0169-5002, 9 p.Article

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapyGREEN, M. D; KOELBL, H; ZANI, V et al.Annals of oncology. 2003, Vol 14, Num 1, pp 29-35, issn 0923-7534, 7 p.Article

Bacillary angiomatosis in an HIV seronegative patient on systemic steroid therapySCHWARTZ, R. A; GALLARDO, M. A; KAPILA, R et al.British journal of dermatology (1951). 1996, Vol 135, Num 6, pp 982-987, issn 0007-0963Article